Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02917759 · ClinicalTrials.gov registry record
Liver and Biliary Tumor Tissue Registry
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT02917759: Clinical Trial study, sponsored by Mayo Clinic.
NCT02917759 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02917759 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Patients having surgery to remove a liver or biliary tissue mass or having a biopsy of a mass or lesion will have a tissue sample collected and stored for future research of liver and biliary diseases. A blood sample may also be collected at the time of enrollment.
Primary Outcome
The number of successful individual patient derived xenografts that are established beyond the second passage in immunodeficient mice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2014-02 |
| Est. Completion | 2025-12 |
Why NCT02917759 stopped before completion
NCT02917759 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02917759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02917759 about?
NCT02917759 is a clinical study titled "Liver and Biliary Tumor Tissue Registry". Patients having surgery to remove a liver or biliary tissue mass or having a biopsy of a mass or lesion will have a tissue sample collected and stored for future research of liver and biliary diseases. A blood sample may also be collected at the time of enrollment.
What is the current status of trial NCT02917759?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 2014-02. Estimated completion is 2025-12.
Who is sponsoring clinical trial NCT02917759?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia